MoneySimpler Launches AI Automated Trading App; Indian Users See Profitability Soar Cinedigm Reports First Quarter Fiscal 2022 Results and Files Form 10-Q Reporting Net Income of $5.2 Million
Total Revenues of $15 Million up 149% Year-Over-Year Streaming Revenues up 181% Year-Over-Year Ad-Supported Streaming…
ZoomAway Announces Change of Auditor
VANCOUVER, BC / ACCESSWIRE / September 9, 2021 / ZoomAway Technologies Inc. (TSXV:ZMA) (OTCQB:ZMWYF) (the…
Pond Technologies Adds Information Regarding Insider Participation in Recently Completed Private Placement
MARKHAM, ON / ACCESSWIRE / September 9, 2021 / Further to the press release dated…
BlackHagen Design to Demo Virtual Reality Methods for Product Development at Boston’s BIOMEDevice
DUNEDIN, FL / ACCESSWIRE / September 9, 2021 / BlackHägen Design, a multidisciplinary, user-research and…
CIBT Provides Update on its Portfolio of Academic Assets and Real Estate Investments
VANCOUVER, BC / ACCESSWIRE / September 9, 2021 / CIBT Education Group Inc. (TSX:MBA)(OTCQX:MBAIF) (“CIBT”…
Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Launches PKU GOLIKE(R) KRUNCH in Germany and Italy
APR Expands PKU GOLIKE(R) Product Line with More Convenient, Chewable Tablet Option GENEVA, SWITZERLAND /…
EQ Partners with SafeGraph to Create Canada’s Largest Geospatial Dataset
Data Integration Partnership of Leading Geospatial Companies Further Strengthens EQ’s Proprietary LOCUS Platform TORONTO, ON…
JD Bancshares, Inc. Announces Participation in the Raymond James 2021 US Bank Conference
JENNINGS, LA / ACCESSWIRE / September 9, 2021 / JD Bancshares, Inc. (OTCQX:JDVB), the bank…
GBX International Group Announces New Business Model for 2021 and Beyond
NEWPORT BEACH, CA / ACCESSWIRE / September 9, 2021 / GBX International Group, Inc. (OTC…
LightPath Technologies Reports Financial Results for Fiscal Year and Fourth Quarter 2021
CEO Sam Rubin Unveils Mission for Leadership in Global Photonics Value Chain ORLANDO, FL /…
Adocia to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
LYON, France, Sept. 10, 2021 (GLOBE NEWSWIRE) — Adocia (Euronext Paris: FR0011184241 – ADOC), a…
CytoDyn Announces Treatment of the First Patient in its Pivotal Phase 3 COVID-19 Trial in Brazil for Patients with Severe Symptoms
An interim analysis will be conducted 28 days following enrollment of 245 patients (40% of…
Impel NeuroPharma Announces Pricing of $45.0 Million Public Offering
SEATTLE, Sept. 09, 2021 (GLOBE NEWSWIRE) — Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical…
InMed Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
VANCOUVER, British Columbia, Sept. 09, 2021 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the…
T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting the Mu B.1.621 and Iota B.1.526 Variants of the SARS-CoV-2 Virus
LEXINGTON, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
BioCardia Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021 (Virtual Conference)
SAN CARLOS, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. (Nasdaq: BCDA), today announced it…
atai Life Sciences and Introspect Digital Therapeutics to test novel digital therapeutic approach in patients receiving ketamine for treatment resistant depression
BERLIN and SAN DIEGO, Sept. 09, 2021 (GLOBE NEWSWIRE) — atai Life Sciences (Nasdaq: ATAI) (“atai”), a clinical-stage…
Gain Therapeutics to Present at 2021 International Virtual GM1 Community Conference
BETHESDA, Md., Sept. 09, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or…
EyeGate to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
WALTHAM, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or…
Arcutis to Present at Upcoming Investor Conferences
WESTLAKE VILLAGE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage…